News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Exelixis, Inc. (EXEL) Said to Hire Goldman, Sachs & Co. to Field Possible Takeover Approaches; Shares Rise on Speculation



4/12/2011 7:09:59 AM

Bloomberg -- Exelixis Inc. (EXEL) is working with Goldman Sachs Group Inc. (GS) to prepare for potential takeover offers after its experimental drug helped prostate-cancer patients in a study, said people with knowledge of the matter.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES